期刊文献+

Salivary IgA enhancement strategy for development of a nasal-spray anti-caries mucosal vaccine 被引量:4

Salivary IgA enhancement strategy for development of a nasal-spray anti-caries mucosal vaccine
原文传递
导出
摘要 Dental caries remains one of the most common global chronic diseases caused by Streptococcus mutans,which is prevalent all over the world.The caries prevalence of children aged between 5-6 years old in China is still in very high rate.A potent and effective anti-caries vaccine has long been expected for caries prevention but no vaccines have been brought to market till now mainly due to the low ability to induce and maintain protective antibody in oral fluids.This review will give a brief historical retrospect on study of dental caries and pathogenesis,effective targets for anti-caries vaccines,oral immune system and immunization against dental caries.Then,salivary IgA antibodies and the protective responses are discussed in the context of the ontogeny of mucosal immunity to indigenous oral streptococcal.The methods and advancement for induction of specific anticaries salivary sIgA antibodies and enhancement of specific anti-caries salivary sIgA antibodies by intranasal immunization with a safe effective mucosal adjuvant are described.The progress in the enhancement of salivary sIgA antibodies and anticaries protection by intranasal immunization with flagellin-PAc fusion protein will be highlighted.Finally,some of the main strategies that have been used for successful mucosal vaccination of caries vaccine are reviewed,followed by discussion of the mucosal adjuvant choice for achieving protective immunity at oral mucosal membranes for development of a nasal-spray or nasal-drop anti-caries vaccine for human. Dental caries remains one of the most common global chronic diseases caused by Streptococcus mutans, which is prevalent all over the world. The caries prevalence of children aged between 5-6 years old in China is still in very high rate. A potent and effective anti-caries vaccine has long been expected for caries prevention but no vaccines have been brought to market till now mainly due to the low ability to induce and maintain protective antibody in oral fluids. This review will give a brief historical retrospect on study of dental caries and pathogenesis, effective targets for anti-caries vaccines, oral immune system and im- munization against dental caries. Then, salivary IgA antibodies and the protective responses are discussed in the context of the ontogeny of mucosal immunity to indigenous oral streptococcal. The methods and advancement for induction of specific anti- caries salivary sIgA antibodies and enhancement of specific anti-caries salivary sIgA antibodies by intranasal immunization with a safe effective mucosal adjuvant are described. The progress in the enhancement of salivary sIgA antibodies and anti- caries protection by intranasal immunization with flagellin-PAc fusion protein will be highlighted. Finally, some of the main strategies that have been used for successful mucosal vaccination of caries vaccine are reviewed, followed by discussion of the mucosal adjuvant choice for achieving protective immunity at oral mucosal membranes for development of a nasal-spray or nasal-drop anti-caries vaccine for human.
作者 YAN HuiMin
出处 《Science China(Life Sciences)》 SCIE CAS 2013年第5期406-413,共8页 中国科学(生命科学英文版)
基金 supported by the National Key Research and Development Program,Ministry of Science and Technology of China(2007BAI28B04) the National Science and Technology Major Project on Major Infectious Diseases(2012ZX10001-008,2008ZX10001-010)
关键词 mutans streptococci secretory IgA PAC mucosal immunization caries vaccine 疫苗接种 粘膜免疫 免疫球蛋白 防龋齿 分泌型 滴鼻 保护性抗体 变形链球菌
  • 相关文献

参考文献2

二级参考文献15

  • 1Forester H, Hunter N, Knox KW.Characteristics of a high molecular weight extracellular protein of Streptococcus mutans.J Gen Microbiol, 1983,129:2779-2788.
  • 2Okahashi N, Sassakawa C, Yoshikawa M, et al. Cloning of a surface protein antigengene from serotype c Streptococcus mutans. Mol Microbiol,1989,3:221-228.
  • 3Brandy LJ, Cvitkovitch DG, Geric CM, et al. Delection of the central proline-richrepeat domain results in altered antigenicity and lack of surface expression of theStreptococcus mutans P1 adhesin molecule. Infect Immun, 1998,66:4274-4282.
  • 4Matsushita K, Nisizawa T, Nagaoka S, et al. Identification of antigenic epitopes ina surface protein antigen of Streptococcus mutans in humans. Infect Immun, 1994,62:4034-4042.
  • 5Klavinskis LS, Barnfield C, Gao L, et al. Intranasal immunization with plasmidDNA-Lipoid complexes elicits mucosal immunity in the female genital and rectal tracts. JImmunol,1999,162:254-262.
  • 6Sasaki S, Hamajima K, Fukushima J, et al. Comparison of intranasal andintramuscular immunization against human immunodeficienty virus type 1 with aDNA-monophosphoryl lipid A adjuvant vaccine. Infect Immun, 1998,66:823-826.
  • 7Davis HL,Michel ML, Mancine M, et al.Direct gene transfer in skeletal muscle;plasmid DNA based immunization against the hepatitis B virus surface antigen.Vaccine,1994,12:1503-1509.
  • 8Kuklin N, Daheshia M, Karem K, et al.Induction of mucosal immunity against herpessimplex virus by plasmid DNA immunization. J Virol, 1997,71:31-38.
  • 9Kawabata S, Terao Y, Fujiwara T, et al. Targeted salivary gland immunization withplasmid DNA elicits specific salivary immunoglobulin A and G antibodies and serumimmunoglobulin G antibodies in mice. Infect Immun, 1999,67:5863-5868.
  • 10Torii M. Lymphoid cell responses to bacterial cell wall components:polyclonal andimmune responses of murine B cells to Streptococcus mutans carbohydrate antigen. JImmunol, 1981,127:2106-2112.

共引文献22

同被引文献19

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部